BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29379304)

  • 1. miR-99a-5p acts as tumor suppressor via targeting to mTOR and enhances RAD001-induced apoptosis in human urinary bladder urothelial carcinoma cells.
    Tsai TF; Lin JF; Chou KY; Lin YC; Chen HE; Hwang TI
    Onco Targets Ther; 2018; 11():239-252. PubMed ID: 29379304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-99a-5p inhibits bladder cancer cell proliferation by directly targeting mammalian target of rapamycin and predicts patient survival.
    Liu Y; Li B; Yang X; Zhang C
    J Cell Biochem; 2019 Dec; 120(12):19330-19337. PubMed ID: 30560585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy inhibition enhances RAD001-induced cytotoxicity in human bladder cancer cells.
    Lin JF; Lin YC; Yang SC; Tsai TF; Chen HE; Chou KY; Hwang TI
    Drug Des Devel Ther; 2016; 10():1501-13. PubMed ID: 27143856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CircMCTP2 enhances the progression of bladder cancer by regulating the miR-99a-5p/FZD8 axis.
    Liu Y; Zhang K; Yang X
    J Egypt Natl Canc Inst; 2024 Mar; 36(1):8. PubMed ID: 38494582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells.
    Lin YC; Lin JF; Tsai TF; Chou KY; Chen HE; Hwang TI
    Asian J Surg; 2017 Sep; 40(5):396-406. PubMed ID: 27519795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-99a-5p: A Potential New Therapy for Atherosclerosis by Targeting mTOR and Then Inhibiting NLRP3 Inflammasome Activation and Promoting Macrophage Autophagy.
    Wang G; Jing SY; Liu G; Guo XJ; Zhao W; Jia XL; Zheng MQ; Tan WY
    Dis Markers; 2022; 2022():7172583. PubMed ID: 35968506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
    Qin H; Liu W
    J Cell Physiol; 2019 Apr; 234(4):3526-3537. PubMed ID: 30443946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
    Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
    BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-99a Inhibits Cell Proliferation and Tumorigenesis through Targeting mTOR in Human Anaplastic Thyroid Cancer.
    Huang HG; Luo X; Wu S; Jian B
    Asian Pac J Cancer Prev; 2015; 16(12):4937-44. PubMed ID: 26163618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-99a-5p induces cellular senescence in gemcitabine-resistant bladder cancer by targeting SMARCD1.
    Tamai M; Tatarano S; Okamura S; Fukumoto W; Kawakami I; Osako Y; Sakaguchi T; Sugita S; Yonemori M; Yamada Y; Nakagawa M; Enokida H; Yoshino H
    Mol Oncol; 2022 Mar; 16(6):1329-1346. PubMed ID: 35148461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-99a-5p inhibits glycolysis and induces cell apoptosis in cervical cancer by targeting RRAGD.
    Wang G; Lu Y; Di S; Xie M; Jing F; Dai X
    Oncol Lett; 2022 Jul; 24(1):228. PubMed ID: 35720506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-99a antitumor activity in human breast cancer cells through targeting of mTOR expression.
    Hu Y; Zhu Q; Tang L
    PLoS One; 2014; 9(3):e92099. PubMed ID: 24637915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway.
    Liu S; Zhang Y; Huang C; Lin S
    J Cell Biochem; 2020 Feb; 121(2):1475-1490. PubMed ID: 31498483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity.
    Martin EC; Rhodes LV; Elliott S; Krebs AE; Nephew KP; Flemington EK; Collins-Burow BM; Burow ME
    Mol Cancer; 2014 Oct; 13():229. PubMed ID: 25283550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer.
    Zhang L; Liu XL; Yuan Z; Cui J; Zhang H
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4663-4672. PubMed ID: 31210292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-99a-5p alleviates atherosclerosis via regulating Homeobox A1.
    Han Z; Guan Y; Liu B; Lin Y; Yan Y; Wang H; Wang H; Jing B
    Life Sci; 2019 Sep; 232():116664. PubMed ID: 31325426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-99a inhibits cell proliferation of nasopharyngeal carcinoma by targeting mTOR and serves as a prognostic factor.
    Wu SH; Han L; Lu BC; Wang HY; Zheng CP
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2053-2061. PubMed ID: 30915749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW; Wang SH; Wei X; Hou YZ; Li ZH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-99a-5p regulates proliferation, migration and invasion abilities of human oral carcinoma cells by targeting NOX4.
    Shi Y; Bo Z; Pang G; Qu X; Bao W; Yang L; Ma Y
    Neoplasma; 2017; 64(5):666-673. PubMed ID: 28592118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression.
    Sun G; Li Z; He Z; Wang W; Wang S; Zhang X; Cao J; Xu P; Wang H; Huang X; Xia Y; Lv J; Xuan Z; Jiang T; Fang L; Yang J; Zhang D; Xu H; Xu Z
    J Exp Clin Cancer Res; 2020 Nov; 39(1):246. PubMed ID: 33198772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.